Effect of subdermal levonorgestrel contraceptive implants, NORPLANT®, on liver functions
- 30 November 1984
- journal article
- Published by Elsevier BV in Contraception
- Vol. 30 (5), 407-412
- https://doi.org/10.1016/0010-7824(84)90032-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Effect of levonorgestrel contraceptive implants, NORPLANT®, on blood coagulationContraception, 1984
- Effect of oral contraception on serum bile acidInternational Journal of Gynecology & Obstetrics, 1984
- A two-year experience with NORPLANT (R) implants in Assiut, EgyptContraception, 1984
- Clinical chemistry in women treated with levonorgestrel implants (NORPLANT™∗∗NORPLANT™is the Population Council's trademark for subdermal implants containing levonorgestrel.) or a TCu 200 IUDContraception, 1983
- Effects of oral contraception on liver function tests and serum proteins in women with active schistcsomiasisContraception, 1982
- Effects of oral contraception on liver function tests and serum proteins in women with past viral hepatitisContraception, 1982
- A five-year clinical trial of levonorgestrel silastic implants (Norplant™)Contraception, 1982
- Clinical chemistry in women treated with progestogen implantsContraception, 1978